Oragenics to Participate in Two Investment Conferences During March

Rhea-AI Summary

Oragenics, Inc. (NYSE American: OGEN) announced that its CEO, Alan Joslyn, Ph.D., will participate in two virtual investment conferences in March 2021. The events are the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10 and the Roth Conference on March 15-17. A prerecorded presentation for the Roth Conference will be available on the Company's website starting March 9. Oragenics focuses on developing a vaccine for COVID-19 and novel antibiotics, leveraging research from the National Institutes of Health.

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), today announced that Alan Joslyn, Ph.D., President and Chief Executive Officer of Oragenics, will participate in two virtual investment conferences during the month of March, as follows:

• The H.C. Wainwright Global Life Sciences Virtual Conference with one-on-one meetings being held March 9-10, 2021
• The Virtual 33^rd Annual Roth Conference with one-on-one meetings being held March 15-17, 2021

The Roth Capital Partners presentation will be prerecorded and available in the Investors section of the Company’s website beginning March 9, 2021. Institutional and other investors interested in scheduling a one-on-one meeting with Oragenics during any of these conferences should contact their sales representative at the sponsoring investment bank.

About Oragenics, Inc.

Oragenics, Inc. is focused on the creation of the Terra CoV-2 development of effective treatments for novel antibiotics against infectious disease. The Company is dedicated to the development and commercialization of a vaccine candidate providing specific immunity from novel coronavirus. The Terra CoV-2 immunization leverages coronavirus spike protein research conducted by the National Institute of Health. In addition, Oragenics has an exclusive worldwide channel collaboration with ILH Holdings, Inc. (n/k/a Eleszto Genetika, Inc.), relating to the development of novel lantibiotics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005308/en/

FAQ

What conferences will Oragenics participate in March 2021?

Oragenics will participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10 and the 33rd Annual Roth Conference on March 15-17.

Who is the CEO of Oragenics?

Alan Joslyn, Ph.D., is the President and CEO of Oragenics.

When will the Roth Conference presentation be available?

The prerecorded Roth Conference presentation will be available on Oragenics' website starting March 9, 2021.

What is Oragenics' focus for vaccine development?

Oragenics is focused on developing a vaccine candidate for COVID-19, utilizing research on the coronavirus spike protein from the National Institutes of Health.

What is the stock symbol for Oragenics?

The stock symbol for Oragenics is OGEN.